(2026). Clinical outcomes of immune checkpoint inhibitor based therapy in NRG1 fusion positive non small cell lung cancer a retrospective study. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Clinical Outcomes of Immune Checkpoint Inhibitor Based Therapy in NRG1 Fusion Positive Non Small Cell Lung Cancer a Retrospective Study."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Clinical Outcomes of Immune Checkpoint Inhibitor Based Therapy in NRG1 Fusion Positive Non Small Cell Lung Cancer a Retrospective Study."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.